DGX · Full Picture

QUEST DIAGNOSTICS INC — the full picture

Trailing window · 2026-05-11 to 2026-08-09

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

1. Revenue Performance and Mix · Revenue growth & mixPriority 65
   +10.2% revenue (realized); quote_verified
   Quest Diagnostics reported strong quarterly earnings, beating estimates with $3.12 per share and a 10.2% increase in revenue
2. Market Demand Trends · Demand, orders & backlogPriority 48
   quote_verified
   Empowered Funds LLC reduced its stake in Quest Diagnostics by 61.5% in the first quarter, selling over 15,000 shares
3. Guidance / Outlook · Guidance & outlookPriority 47
   2 forward row(s); quote_verified
   Quest Diagnostics has increased its 2026 revenue and adjusted earnings guidance
4. Cyclospora Testing Surge · UnclassifiedPriority 31
   quote_verified
   Quest Diagnostics is now processing more than 1,500 cyclospora tests a day
5. Procedure Volume Trends · Demand, orders & backlogPriority 31
   quote_verified
   Quest Diagnostics' Q2 results exceeded expectations, driven by volume growth

Threads by pillar

Revenue & Demand Priority 67 · 3 threads

• Revenue Performance and MixPriority 65 · News
• Market Demand TrendsPriority 48 · News
• Procedure Volume TrendsPriority 31 · News

Guidance & Outlook Priority 47 · 1 thread

• Guidance / OutlookPriority 47 · News

Unclassified Priority 31 · 1 thread

• Cyclospora Testing SurgePriority 31 · News

Expected impact by metric